US Glaucoma Market and Competitive Landscape Report 2018 - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Oct 5, 2018--The “US Glaucoma Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.
US Glaucoma Market and Competitive Landscape - 2018, provides comprehensive insights into Glaucoma pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Glaucoma market size and drug sales. This research also provides insights into Glaucoma epidemiology and late stage pipeline.
The research is classified into following sections - Glaucoma overview with definitions, symptoms, etiology, diagnosis, treatment options; Glaucoma pipeline insights covering late stage clinical trials pipeline; Glaucoma prevalence trends by countries; Glaucoma market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries. The research scope includes the market - USA.
Research Scope:Glaucoma pipeline: Find out the drugs in clinical trials for Glaucoma by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Glaucoma epidemiology: Find out the prevalence of Glaucoma in US; prevalence forecast to 2023 Glaucoma products: Identify key products marketed and prescribed for Glaucoma by brand name, by molecule, by company, by branded / generic, in US Glaucoma market size: Find out the market size for Glaucoma drugs in US; Find out how the market advanced from 2014 Glaucoma drug sales: Find out the sales of Glaucoma drugs in US Glaucoma drugs sales forecast: Sales forecast for Glaucoma drugs to 2023 in US Glaucoma market share analysis: Find out the market shares of Glaucoma drugs and outlook in US
Key Topics Covered:
1. Glaucoma: Disease Overview
1.1. Glaucoma Symptoms
1.2. Glaucoma Etiology
1.3. Glaucoma Diagnosis
1.4. Glaucoma Treatment Options
2. Glaucoma Pipeline Insights
2.1. Glaucoma Phase 3 Clinical Trials
2.2. Glaucoma Phase 2 Clinical Trials
2.3. Glaucoma Phase 1 Clinical Trials
3. Glaucoma Epidemiology Analysis
4. US Glaucoma Market Insights
4.1. Marketed Products for Glaucoma in US
4.2. US Glaucoma Market Size & Forecast
4.3. US Glaucoma Product Sales Forecast
For more information about this report visit https://www.researchandmarkets.com/research/hcznhd/us_glaucoma?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181005005413/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Optical Disorders Drugs
INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 10/05/2018 12:35 PM/DISC: 10/05/2018 12:35 PM